Detalhe da pesquisa
1.
Incidence of PSMA PET thyroid incidentaloma depends on analysis method and tracer.
Eur Radiol
; 33(5): 3377-3385, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892644
2.
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Blood
; 136(25): 2927-2932, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331925
3.
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.
Eur J Nucl Med Mol Imaging
; 49(6): 2010-2022, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957526
4.
Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center.
Eur J Nucl Med Mol Imaging
; 49(7): 2392-2400, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031811
5.
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
BMC Cancer
; 22(1): 1018, 2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36163009
6.
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.
Dig Endosc
; 34(1): 163-170, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33928678
7.
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Haematologica
; 105(2): 424-434, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123031
8.
Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs.
Aesthet Surg J
; 40(2): 156-164, 2020 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31242279
9.
High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
Cancer
; 125(6): 990-999, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561773
10.
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
N Engl J Med
; 373(26): 2499-511, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26699166
11.
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial.
Support Care Cancer
; 26(4): 1233-1242, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230548
12.
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Br J Cancer
; 117(3): 306-314, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632726
13.
Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast.
Blood
; 136(11): 1368-1372, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452517
14.
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
BMC Cancer
; 17(1): 112, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173773
15.
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.
Blood
; 124(3): 319-27; quiz 466, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740811
16.
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.
Eur Arch Otorhinolaryngol
; 273(2): 455-64, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25876000
17.
Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.
Eur Arch Otorhinolaryngol
; 273(6): 1557-67, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929413
18.
A new grading system for ototoxicity in adults.
Ann Otol Rhinol Laryngol
; 123(10): 711-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24820112
19.
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
PLoS One
; 18(11): e0294147, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011186
20.
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study.
Blood Adv
; 7(20): 6266-6274, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530622